This document discusses genetic instability. It defines genetic instability as an increased rate of genomic alterations ranging from point mutations to chromosome rearrangements. It describes three main types: nucleotide instability, microsatellite instability, and chromosomal instability. Causes of genetic instability include replication errors, defects in DNA repair pathways, and issues during cell division. Methods for detecting instability include karyotyping, FISH, and array technologies. Genetic instability is a hallmark of cancer and helps accelerate tumor genesis by increasing mutations. Cells use mechanisms like DNA proofreading and cell cycle checkpoints to maintain stability.
ONCOGENE AND PROTOONCOGENE
P53 GENE AND ITS APPLICATION IN CANCER ETIOLOGY
TUMOUR SUPPRESSOR GENE AND BCA AND BAC GENE AND ITS APPLICATION ON THE APOPTOSIS AND DEATH RECEPTORS
ONCOGENE AND PROTOONCOGENE
P53 GENE AND ITS APPLICATION IN CANCER ETIOLOGY
TUMOUR SUPPRESSOR GENE AND BCA AND BAC GENE AND ITS APPLICATION ON THE APOPTOSIS AND DEATH RECEPTORS
An oncogene is a gene that has the potential to cause cancer. In tumor cells, they are mutated or expressed at high levels. Most normal cells undergo a programmed form of rapid cell death (apoptosis) when critical functions are altered.
Cell within a tumor that possess the capacity to self-renew and to cause the heterogeneous lineages of cancer cells that comprise the tumor”.
“CSC can thus only be defined experimentally by their ability to recapitulate the generation of a continuously growing tumor”.
INTRODUCTION
ROLE IN CELL LINE CHARACTERIZATION
CAUSES OF TRANSFORMATION
METHODS OF TRANSFECTION
CHARACTERISTICS OF TRAANSFORMED CELLS
GENETIC INSTABILITY
IMMORTALIZATION
ABRERANT GROWTH CONTROL
TUMORIGENECITY
CHROMOSOMAL ABERATION
APPLICATION
CONCLUSION
REFERENCE
Majority of cancer lead by point mutation in p53 gene. which is also known as "guardian of genome". this mutation leads conversion of normal cell into cancerous cell.
Comparative genomic hybridization is a molecular cytogenetic method for analysing copy number variations (CNVs) relative to ploidy level in the DNA of a test sample compared to a reference sample, without the need for culturing cells
An oncogene is a gene that has the potential to cause cancer. In tumor cells, they are mutated or expressed at high levels. Most normal cells undergo a programmed form of rapid cell death (apoptosis) when critical functions are altered.
Cell within a tumor that possess the capacity to self-renew and to cause the heterogeneous lineages of cancer cells that comprise the tumor”.
“CSC can thus only be defined experimentally by their ability to recapitulate the generation of a continuously growing tumor”.
INTRODUCTION
ROLE IN CELL LINE CHARACTERIZATION
CAUSES OF TRANSFORMATION
METHODS OF TRANSFECTION
CHARACTERISTICS OF TRAANSFORMED CELLS
GENETIC INSTABILITY
IMMORTALIZATION
ABRERANT GROWTH CONTROL
TUMORIGENECITY
CHROMOSOMAL ABERATION
APPLICATION
CONCLUSION
REFERENCE
Majority of cancer lead by point mutation in p53 gene. which is also known as "guardian of genome". this mutation leads conversion of normal cell into cancerous cell.
Comparative genomic hybridization is a molecular cytogenetic method for analysing copy number variations (CNVs) relative to ploidy level in the DNA of a test sample compared to a reference sample, without the need for culturing cells
Invitation to CryoSymp 2017
The 3rd ISHS International Symposium on Plant Cryopreservation (CryoSymp2017) http://www.ishs.org/symposium/493 will be held in Cayo Guillermo, Ciego de Ávila (Cuba) from 22 to 26 May, 2017. This is a continuation of the Symposiums held in Leuven, April, 2009 (Belgium), and in Fort Collins, Colorado, August, 2013 (USA). The CryoSymp2017 is under ISHS guide http://www.ishs.org and will be co-organized together with the 11th International Congress on Plant Biotechnology and Agriculture BioVeg2017 http://bioveg.bioplantas.cu.
All scientists, students and professionals interested in cryobiology and ex situ plant preservation are invited to attend. The symposium will include in depth analyses of basic research in the cryobiology of living cells as well as reports on state-of-the-art methods, research and successes with cryopreservation of selected horticultural and agricultural crops.
The program will include oral and posters sessions on topics dealing with fundamental aspects of cryobiology as well as with the application of cryopreservation in germplasm collections. The symposium will focus on presentations of selected topics, keynote addresses on cryopreservation of plants, discussions and interaction around poster presentations. Moreover, one day will be dedicated to practical session at Bioplantas Center, University of Ciego de Avila.
Telomerase Inhibition as Novel Cancer Therapeutic MethodVincensanicko
Telomere in cancerous cells is conserved even after several rounds of cell division. By identifying the responsible protein in this process, i.e. telomerase, researchers have utilised it as a novel target for cancer treatment. So, how is the telomerase targetted? Are you ready to discover the truth?
A genetic disorder is a disease caused by a different form of a gene called a variation,
or an alteration of a gene called a mutation. Many diseases have a genetic aspect. Some,
including many cancers, are caused by a mutation in a gene or group of genes in a person's
cells. These mutations can occur randomly or because of an environmental exposure such as
cigarette smoke.
Other genetic disorders are inherited. A mutated gene is passed down through a family
and each generation of children can inherit the gene that causes the disease. Still other
genetic disorders are due to problems with the number of packages of genes called
chromosomes. In Down syndrome, for example, there is an extra copy of chromosome 21.
If you know that you have a genetic problem in your family, you can have genetic testing to see if your baby could be affected.
NIH: National Human Genome Research Institute
Tandem Repeats and Satellite DNA in Bovideae - Colloquium on Animal CytogeneticsPat (JS) Heslop-Harrison
Tandemly repeated satellite DNA in the Artiodactyla - a lecture
Tandemly repeated, satellite, DNA sequences are an abundant component of the genome of most species, including the Artiodactyla. Multiple DNA familes are present, each in long tandem arrays, with members of each family present on one or more chromosomes at characteristic positions. In particular, several familes are located at the centromeres of most chromosomes, including acrocentrics, metacentrics and the sex chromosomes. Individual arrays are made up of variants of particular sequence motifs, which may be longer than 1,500 bp. In this presentation, we will discuss aspects of the evolution of repetitive sequences within and between chromosomes, with comparative data between different species. With pig, we will show details of the localization of tandem repeats at meiosis, and how these sequences relate to sequence amplification and loss, as well as the epigenetic behaviour of the resulting heterochromatin. In the Bovinae, we will show how molecular cytogenetic methods are essential to build up a full picture of the behaviour and distribution of satellite DNA where current sequencing methods are unable to assemble the sequences blocks accurately.
P. Heslop-Harrison1, T. Schwarzacher1 and R. Chaves2 (Phh4@le.ac.uk)
University of Leicester, Biology, Leicester LE1 7RH UK; 2Institute for Biotechnology and Bioengineering, Centre of Genomics and Biotechnology, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal
Introduction to Cancer
Stem cells and cancer cells
major pathways that lead to formation of tumors.
Tumor Supressors
Colon cancer to prove Knudson hypothesis.
The modern treatments available to treat cancer.
Cancer is mainly caused by the conversion of proto-oncogenes into oncogenes. The process is known as oncogenesis.
This slide will help to get an idea about oncogenesis and also the proto-oncogenes which get converted.
DNA Methylation and Epigenetic Events Underlying Renal Cell Carcinomaskomalicarol
Renal cell carcinoma (RCC) refers to a group of tumors that develop from the epithelium of the kidney tubes, including clear cell
RCC, papillary RCC, and chromophobe RCC. Most clear cell renal
carcinomas have a large histologic subtype, genetic or epigenetic
genetic von Hippel-Lindau (VHL). A comprehensive analysis of
the genetic modification genome suggested that chromosome 3p
loss and chromosome gains 5q and 7 may be a significant copy
defect in the development of clear kidney cell cancer. A more potent renal cell carcinoma may develop if chromosome 1p, 4, 9,
13q, or 14q is also lost. Renal carcinogenesis is not associated with
chronic inflammation or histological changes. However, regional hypermethylation of DNA in CpG C-type islands has already
accumulated in cancer-free kidney tissue, implying that the presence of malignant kidney lesions may also be detected by modified
DNA methylation. Modification of DNA methylation in cancerous
kidney tissue may advance kidney tissue to epigenetic mutations
and genes, leading to more serious cancers and even determining
a patient’s outcome
The epigenetic regulation of DNA-templated processes has been intensely studied over the last 15
years. DNA methylation, histone modification, nucleosome remodeling, and RNA-mediated targeting regulate many biological processes that are fundamental to the genesis of cancer. Here, we
present the basic principles behind these epigenetic pathways and highlight the evidence suggesting that their misregulation can culminate in cancer. This information, along with the promising clinical and preclinical results seen with epigenetic drugs against chromatin regulators, signifies that it
is time to embrace the central role of epigenetics in cancer.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
2. Content
2
Introduction
Genetic Instability
Types of Genetic Instability
Causes of Genetic Instability
Methods for detection and analysis of genome
instability
Genome instability and tumor genesis
Major mechanisms used to maintain genomic
instability
Discussion
Summery
References
3. Introduction
3
The genome is an organism’s complete set of
DNA and is organized into chromosomes
containing genes that encode for hereditary traits.
As our cells grow reproduce and die, DNA is
repeatedly replicated and repaired and bits and
pieces of its sequences are changed in the
process, thus producing mutations.
These mutations create genetic variation and it is
proven that genetic mutation is key to our
evolution and survival.
But ,mutations are not always beneficial, they can
be harmful leading to genetic diseases.
When these mutations occur in an increased
levels genetic instability takes place.
4. Genetic Instability
4
A range of genetic alterations from point
mutations to chromosome rearrangements
- Aguilera and Gonzales,2008
An increased rate of genomic alteration although
some use the term to describe the state of the
altered cancer genome.
- Kwei et al.,2010
A variety of DNA alterations, encompassing single
nucleotide to whole chromosome changes.
- Pikor et al., 2013
5. 5
A transient or persistent state that increases the
spontaneous mutation rate, leading to gross
genetics alterations such as rearrangements and
changes in chromosome number.
- Pikor et al., 2013
Commonly ,
Genetic alterations
Increased rates
Nucleotides to Chromosomes
6. Types of Genetic Instability
6
Based on the level of disruption,
1) Nucleotide Instability
2) Microsatellite Instability
3) Chromosomal Instability
- Pikor et al.,
2013
7. 01) Nucleotide Instability
7
Due to replication errors and impairment of the
base excision repair and nucleotide excision
repair pathways.
Subtle sequence changes involving only one or
few nucleotides , such as
Substitutions
Deletions
Insertions
Mitochondrial genome also displays this.
10. Detection of G>C varient encoding a Gly>Arg amino acid change by
sanger sequencing in two lung cancers.
Source –Pikor et al.,2013
10
11. 02)Microsatellite Instability
11
Repetitive DNA sequences ,comprising
1-6 bp located throughout the genome.
Size is highly variable.
Results from defects in mismatch repair
,specifically alterations of the
MLH1,MSH2,MSH6 and PMS2 genes,
which causes deletions or random
insertions and expansion of
microsatellites and a hyper mutable
phenotypes.
12. Defects in Mismatch repair lead to the expansion or contraction of
microsatellites throughout the genome.
Source-Pikor et al., 2013
12
13. Disorders associate with MIN
13
Gastric,Endometrial,Ovarian,Lung and
Colorectal cancers.
Lynch syndrome
14. 03)Chromosomal Instability
14
Most prominent form.
90% of human cancers exhibiting chromosomal
abnormalities and aneuploidy.
An increase in the rate of gain or loss of segmental
and whole chromosomes during cell divisions.
CIN tumors are characterized by
Aneuploidy
Amplifications
Deletions
Translocations
Inversions
18. 18
Also occur because of alterations in,
Mitotic Timing
Mitotic checkpoint control
Microtubule or centrosome dynamics
Double strand break repair
These alterations lead to karyotypic instability
and growth of tumor populations.
19. Disorders associate with CIN
19
Breast,prostate .non small cell lung cancer,
leukaemia,Neuroblastoma,Hodgkins and non
Hodgkins lymphoma,Head and Neck cancer.
Angelmen syndrome,Williams Syndrome , Cri du
chat syndrome.
21. Causes of genetic instability
21
Replication dysfunction as a major
source of instability .
Low replication Initiation Density
Untimely Initiation causing Re-
replication
Faulty replication fork progression
S phase checkpoint Dysfunction
Defective Nucleosome Assembly and
remodeling
22. 22
Failures in post replicative repair and homologous
recombination
Site specific hotspots
DNA repeats
Fragile sites
Non B DNA structures ,G-Quadruplexes and
Telomeres
DNA-Protein barriers to replication fork
progression
Cell physiology and metabolism
Aging
23. Methods for the detection and
analysis of genome instability
23
Single cell approach
Karyotyping
Fluorescence insitu Hibridization –Fish
Single cell sequencing
Multiple annealing
Looping based amplification cycles
25. 25
Multi cell approach
Flow cytometry – measures cells in a
suspension as they pass through a laser scatter
light and emit fluorescence can be used to detect
cellular aneuploidy.
Array comparative genomic hybridization-
Offers the ability to quantitatively detect and
visualize whole and segmental chromosomal
alterations .
SNP arrays- enable more precise
mapping of copy number alterations.
PCR-Amplify microsatellite regions and
lengths of tandem repeats.
28. Genetic Instability and Tumor
genesis
28
Cancer is a genetic disease.
Tumor cells contain multiple mutations ,ranging
from single nucleotide sequences changes and
numerical alterations of chromosomes.
Collectively , these mutations are referred to as
genome instability ,which may be predisposed
through inherited ,germline mutations as in the
case of p53,BRCA1,BRCA2 or acquired as
somatic mutations throughout an individuals
lifetime.
-
Chen ,2015
29. 29
Acquisition of
some form of
inherent genomic
instability is a
hallmark of tumor
genesis.
- Sieber etal .,
2013
30. Arguments for genomic instability as
the engine of tumor genesis
30
Tumors harbor too many mutations to be
explained by anything other than underlying
genomic instability.
The probability of a tumor acquiring enough
mutations for the full, malignant phenotype is too
low unless the cells have an unstable genome.
Humans and model organisms with inherent
genomic instability are prone to tumors.
In some tumors , there is direct evidence that
some pathways that are involved in maintaining
genomic integrity are defective.
32. 32
DNA polymerases and genetic instability-
In mammals it is limited.
Genetic instability in proofreading of
DNApolymerases increases the incidences of
lymphoma and epithelial tumors in mice, so can be
in humans.
DNA repair enzymes and genetic instability
Xeroderma pigmentosum patients- defect in
nucleotide excision repair pathway
33. 33
Chromosomal instability
Aneuploidy ,gross chromosomal translocations and
molecular loss of heterozygocity without grossly
visible karyotypic changes are common in all type of
tumors.
Cell cycle checkpoints and genetic instability
The most extensively checkpoint genes p53 and
pRb are among the most frequently mutated in
human cancers.
Other checkpoint genes include the ATM gene,
which is mutated in Ataxia telangiectasia .
There is also evidence that BRCA1,BRCA2 inherited
breast and ovarian cancer .
35. 35
Cancer typically occurs late in life and
evolves over decades.
Amodest reduction in the rate of
carcinogenesis could delay the onset of
cancer by decades.
Enhanced genetic stability could slow
down carcinogenesis in a meaningful
way ,leading to “PREVENTION by
DELAY”.
Prevention by delay may be particularly
applicable for cancers associated with
prolonged chronic inflammation due to
36. 36
A reduction in the rate of mutation accumulation
by only two fold ,could delay the clinical
appearance of the tumor from age 50 to age 90.
Compensation of the altered DNA mechanisms or
altered DNA polymerases in promoting genetic
instability would be more challenging with current
technologies , as it might require comprehensive
gene therapy.
37. Role of genetic instability in relation
to therapy
37
Genetic instability may play a role in the
mechanism of action of chemotherapy.
Genetic instability not only increases the rate of
acquiring mutations which may be essential for
carcinogenesis,but also accelerates the
acquasition of deleterious mutations which
reduces the fitness of clones potentially leading to
their extinction.
38. 38
Beyond a critical value, further increases in
genetic instability are likely to exceed the
optimum and lead to extinction of clones.
The majority of chemotherapeutic agents
interfere with aspects of DNA metabolism and
are mutagens.
If the cancer consists of genetically unstable
cells, further increased mutagenesis due to
chemotherapy could lead to accumulate
deleterious mutations and extinction of
malignant clones.
Some scientists have suggested that in
addition to directly causing mutations
,chemotherapy may select for genetic
39. Major mechanisms used to maintain
genetic stability
39
Normal mammalian cells mainly resort
to four mechanisms to maintain their
genomic stability during cell
division.(Shen,2011)
1)High fidelity of DNA replication in S
phase
2)Accurate distribution of chromosomes
among daughter cells during mitosis
3)Error-free repair of sporadic DNA
damage throughout the cell cycle.
41. 1)High fidelity of DNA replication in S
phase
41
High fidelity of base pairing and proofreading
activities by DNA polymerases.
Mismatch repair macinery to correct not only
mismatched bases ,but also secondery DNA
structures resulted from replication slippage.
Timely resolution of stalled replication forks.
Maturation of okazaki fragments.
Replication licensing mechanisms to ensure
that the entire genome is duplicated
completely .
Coordinated reassembly of chromosomes
from newly synthesized DNA.
42. 2)Accurate distribution of chromosomes
among daughter cells during mitosis
42
During mitosis ,the sister chromatids are equally
distributed in daughter cells .This is mainly
coordinated by many processes.
Chromosome condensation
Sister chromatid cohesion
Centrosome duplication and separation
Kinetochore assembly and attachment
Spindle formation and checkpoint
Chromosome segregation
Cytokinesis
Deregulation of above processes cause
chromosomal instability.
43. 3)Error-free repair of sporadic DNA damage
throughout the cell cycle.
43
Throughout the cell cycle ,the genome
encounters various forms of spontaneous and
induced DNA damages.
These damages are repaired by severel well
defined repair pathways.
Error prone repair- Completion of some of the
repair processes to fix chemical damages to the
DNA double helix may cause alterations or
rearrangements.
Error free repair- Fix the damage to the DNA,but
also preserve the original genome structure.
44. 4)Cell cycle progression and
checkpoint control
44
Cell cycle checkpoints are built to
ensure that progression from one phase
to the next under a condition of
minimum risk of genomic alteration.
This is accomplished by delaying the
entry into the next phase until the risk
factors are removed.
Another important function of cell cycle
checkpoint is to effectively trigger some
processes to eliminate the severely
45. 45
The G1/S checkpoint is to restrict damage
cells entering S phase .
The G2/M checkpoint prevents cells from
premature entry into mitosis.
The intra S checkpoint helps to delay the
fringe of replication of origins or slows down
DNA duplication during S phase.
The mitotic spindle checkpoint ensures
normal spindle function in order to minimize
chromosome segregation errors.
The post mitotic checkpoint can prevent
daughter cells of abnormal mitosis from
entering the next interphase.
46. Discussion
46
Genetic Instability is a hall mark of cancer.
Nucleotide instability is the rarest among three
types of genetic instabilities.
Ionizing radiation, dietary factors, lack of nutrition
will also can be considered as causes of genetic
instability.
Detection methods of genetic instabilities exhibit
both advantages and disadvantages. Those
techniques must be developed.
It is an argument .the role of genetic instability in
cancer.
47. Summary
47
Genetic Instability – Various definitions, but have
common features.
Three types of genetic Instability.
Causes of Genome Instability .
Single cell and multi cell approaches in methods
for the detection and analysis of genomic
instability.
Genetic Instability as a major reason for cancer.
Four major mechanisms used to maintain
genomic stability.
48. References
48
Abdel-Rahman, W. M., Katsura, K., Rens, W., Gorman, P.
A.,Sheer, D., Bicknell, D.(2001). ‘Spectral karyotyping suggests
additional subsets of colorectal cancers characterized by pattern
of chromosome rearrangement. Proceedings of the National
Academy of Sciences of the United States of America,98(5),
2538–2543.
Anderson,G.R.(2001)‘Genomic Instability in Cancer’.Current
Science,18(5):501-507
Beeckmann,A.R. and Loeb,A.L.(2005) ‘ Genetic onstability in
Cancer:Theory and experiment’.Seminars in Cancer
Biology,15:423-435.
Aguilera,A.and Gonzales,B.G.(2008) ‘Genomic Instability: a
mechanistic view of its causes and consequences’.Nature,9:204-
217.
Aguilera,A. and Garcia-Muse,T.(2013) ‘ Causes of Genome
Instability’.Annual Review of Genetics,47:19-50.
49. 49
Charames,G.S. and Bopat,B.(2003) ‘Genomic Instability and
Cancer’.Current Molecular Medicine,3 : 589-596.
Chen,H.Maxwell,C. Connel,M. (2015) ‘ The Generation,Detection
and Prevention of Genomic Instability During Cancer Prognosis
and Metastasis’.Cancer Metastasis,20:15-26.
Dworaczek, H., and Xiao, W. (2007). ‘Xeroderma pigmentosum: a
glimpse into nucleotide excision repair, genetic instability, and
cancer’. Critical Reviews in Oncogenesis, 13(2), 159–177.
Gagos, S., and Irminger-Finger, I. (2005). ‘Chromosome
instability in neoplasia: chaotic roots to continuous growth’. The
International Journal of Biochemistry & Cell Biology, 37(5), 1014–
1033.
Kwei,K.A. Kung,Y. Salari,K. Holcomb,N.I. Pollock,J.R. (2010)
‘Genomic Instability in breast cancer: Pathogenesis and clinical
impications’.Molecular Biology, 4 : 255-266.
Leach, F. S., Nicolaides, N. C., Papadopoulos, N., Liu, B., Jen,J.,
Parsons, R., et al. (1993). ‘Mutations of a mutS homolog in
hereditary nonpolyposis colorectal cancer’.Cell, 75(6), 1215–
1225.
50. 50
Lengauer,C. Kizler,K.W. Vogelestein, B.(1998) ‘Genetic
Instabilities in Human cancers’.Nature,396:643-649.
Muresu, R., Sini, M. C., Cossu, A., Tore, S., Baldinu, P.,
Manca,A.(2002). ‘Chromosomal abnormalities and microsatellite
instability in sporadic endometrial cancer’. European Journal of
Cancer, 38(13), 1802–1809.
Pikor,L. Thu,K. Vucic,E. Lam,W.(2013) ‘The detection and
implication of genome instability in cancer’.Cancer
Metastasis,32:341-352.
Rao,C. and Yamada,H.Y.(2013) ‘Genomic Instability and colon
carcinogenesis;from the perspective view of genes’.Frontiers in
Oncology,3:1-13.
Schvartsman,J.M. Sotillo,R. Benzera,R.(2010) ‘Mitotic
Chromosomal Instability and cancer :Mouse modelling of the
human disease’.Nature.10:102-115.
Shen,S.(2011) ‘Genomic Instability and Cancer:an
Introduction’.Journal of Molecular Biology,3:1-3.
51. 51
Sieber,M.O. Heinmann,K.Tomlinson,P.M.(2003) ‘Genomic
Instability ,The engine of Tumorigenesis?’.Cancer,3:701-707.
Tassan, N., Chmiel, N. H., Maynard, J., Fleming, N.,Livingston,
A. L., Williams, G. T.,(2002). Inherited variants of MYH
associated with somatic G:C→T:A mutations in colorectal
tumors. Nature Genetics, 30(2), 227–232.